Low Rates of Acute Recanalization With Intravenous Recombinant Tissue Plasminogen Activator in Ischemic Stroke: Real-World Experience and a Call for Action

By R. Bhatia, M. Hill, N. Shobha, B. Menon, Simerpreet S. Bal, P. Kochar, T. Watson, M. Goyal, A. Demchuk. Stroke, 2010

717 citations recorded by the source corpus.

Subfields: Epidemiology, Pulmonary and Respiratory Medicine, Rheumatology

View Paper: https://www.semanticscholar.org/paper/a5e7d447311cffb8abda8eaec0b395509e9703df

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. B. Baxter
2. A. Demchuk
3. M. Eesa
4. B. Menon
5. A. Weill
6. J. Rempel
7. J. Thornton
8. A. Shuaib

Citations in the corpus

• Randomized assessment of rapid endovascular treatment of ischemic stroke. (2015, background): “The ESCAPE trial was stopped early on the advice of the data and safety monitoring board because the prespecified boundary for efficacy had been crossed. patients At 22 centers in Canada (11 centers), the United States (6), South Korea (3), Ireland (1), and the * The intervention group was assigned ”